Red degeneration of a uterine fibroid following the administration of gonadotropin releasing hormone agonists

J Obstet Gynaecol. 2016 Nov;36(8):1018-1019. doi: 10.1080/01443615.2016.1234449. Epub 2016 Oct 17.

Authors

Kae Hachiya¹, Hiroki Kato¹, Shimpei Kawaguchi², Toshihisa Kojima², Yukiko Nishikawa³, Sayaka Fujiwara³, Masayuki Matsuo¹

Affiliations

¹ a Department of Radiology , Gifu University School of Medicine , Gifu , Japan.
² b Department of Radiology , Gifu municipal Hospital , Gifu , Japan.
³ c Department of Obstetrics and Gynaecology , Kizawa Memorial Hospital , Minokamo City , Japan Gifu.

PMID: 27750451
DOI: 10.1080/01443615.2016.1234449

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Female
Gonadotropin-Releasing Hormone / adverse effects*
Gonadotropin-Releasing Hormone / agonists*
Humans
Infarction / chemically induced*
Leiomyoma / blood supply
Leiomyoma / drug therapy*
Pigmentation
Premenopause

Substances

Gonadotropin-Releasing Hormone